United StatesOndansetron Orally Disintegrating Tablets, USP 4 mg, 30 tablets (3 blistercards of 10), NDC 68462-157-13, Lot 19251311, exp April 2027, manufactured for Glenmark Pharmaceuticals Inc., USA (product of India) and sold nationwide are affected. The recall was issued because blister packs are not fully sealed and tablets may fall out; Preferred Pharmaceuticals repackaged the finished product.
What's being recalled
Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13
Recalling firm: Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ, United States.
How to identify it
Lot #: 19251311, Exp Date April 2027
The hazard
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide within the United States
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)